End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
4.38
CNY
|
-2.67%
|
|
-6.01%
|
-6.41%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,006
|
2,961
|
3,041
|
3,743
|
2,892
|
3,162
|
Enterprise Value (EV)
1 |
3,321
|
3,217
|
3,325
|
4,156
|
3,517
|
3,876
|
P/E ratio
|
21.4
x
|
19
x
|
17.9
x
|
20.8
x
|
15.1
x
|
18.9
x
|
Yield
|
1.13%
|
1.14%
|
1.11%
|
0.99%
|
1.33%
|
-
|
Capitalization / Revenue
|
2.54
x
|
2.4
x
|
2.45
x
|
2.56
x
|
1.68
x
|
1.89
x
|
EV / Revenue
|
2.8
x
|
2.61
x
|
2.68
x
|
2.84
x
|
2.05
x
|
2.32
x
|
EV / EBITDA
|
14.1
x
|
13
x
|
14.2
x
|
15.2
x
|
12.1
x
|
11
x
|
EV / FCF
|
-17.9
x
|
23.5
x
|
44.4
x
|
-35.7
x
|
-13.1
x
|
-30
x
|
FCF Yield
|
-5.6%
|
4.25%
|
2.25%
|
-2.8%
|
-7.62%
|
-3.33%
|
Price to Book
|
1.93
x
|
1.74
x
|
1.64
x
|
1.87
x
|
1.34
x
|
1.38
x
|
Nbr of stocks (in thousands)
|
677,071
|
676,072
|
675,709
|
675,709
|
675,709
|
675,709
|
Reference price
2 |
4.440
|
4.380
|
4.500
|
5.540
|
4.280
|
4.680
|
Announcement Date
|
4/15/19
|
4/23/20
|
4/23/21
|
4/24/22
|
4/21/23
|
4/24/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,186
|
1,232
|
1,242
|
1,461
|
1,720
|
1,671
|
EBITDA
1 |
236
|
247.9
|
234.2
|
274.2
|
290
|
351.3
|
EBIT
1 |
177.4
|
188.5
|
173.3
|
202
|
196.5
|
253.5
|
Operating Margin
|
14.96%
|
15.3%
|
13.95%
|
13.82%
|
11.43%
|
15.17%
|
Earnings before Tax (EBT)
1 |
167.1
|
189.7
|
185.2
|
202.7
|
206.4
|
196.1
|
Net income
1 |
137.4
|
156.3
|
169.4
|
180.3
|
191.6
|
167.4
|
Net margin
|
11.58%
|
12.69%
|
13.64%
|
12.34%
|
11.14%
|
10.02%
|
EPS
2 |
0.2078
|
0.2308
|
0.2507
|
0.2669
|
0.2835
|
0.2471
|
Free Cash Flow
1 |
-185.9
|
136.9
|
74.96
|
-116.4
|
-268.1
|
-129.2
|
FCF margin
|
-15.68%
|
11.11%
|
6.03%
|
-7.97%
|
-15.59%
|
-7.73%
|
FCF Conversion (EBITDA)
|
-
|
55.21%
|
32.01%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
87.56%
|
44.24%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0500
|
0.0500
|
0.0500
|
0.0550
|
0.0570
|
-
|
Announcement Date
|
4/15/19
|
4/23/20
|
4/23/21
|
4/24/22
|
4/21/23
|
4/24/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
314
|
256
|
284
|
413
|
625
|
713
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.332
x
|
1.033
x
|
1.214
x
|
1.506
x
|
2.156
x
|
2.031
x
|
Free Cash Flow
1 |
-186
|
137
|
75
|
-116
|
-268
|
-129
|
ROE (net income / shareholders' equity)
|
8.82%
|
9.31%
|
8.99%
|
8.84%
|
8.85%
|
7.48%
|
ROA (Net income/ Total Assets)
|
3.78%
|
3.56%
|
3.15%
|
3.45%
|
3.09%
|
3.7%
|
Assets
1 |
3,637
|
4,389
|
5,371
|
5,221
|
6,195
|
4,531
|
Book Value Per Share
2 |
2.300
|
2.520
|
2.750
|
2.960
|
3.200
|
3.400
|
Cash Flow per Share
2 |
0.5800
|
0.5100
|
0.5000
|
0.4900
|
0.3500
|
0.1500
|
Capex
1 |
120
|
44.4
|
180
|
248
|
189
|
170
|
Capex / Sales
|
10.16%
|
3.61%
|
14.46%
|
16.97%
|
10.99%
|
10.17%
|
Announcement Date
|
4/15/19
|
4/23/20
|
4/23/21
|
4/24/22
|
4/21/23
|
4/24/24
|
|
1st Jan change
|
Capi.
|
---|
| -6.41% | 409M | | +12.01% | 8.72B | | +36.64% | 2.17B | | -10.22% | 1.09B | | -0.43% | 837M | | +13.26% | 768M | | -11.56% | 624M | | +9.87% | 622M | | +6.74% | 610M | | -4.66% | 577M |
Purification & Treatment Equipment
|